News
UK says it has hit target on commercial trial set-up times
The UK has made progress in its efforts to slash set-up times for clinical trials, one of the factors blamed for a decline in industry-backed studies.
News
Lift for UK healthtech as fund bags £100m from national bank
A new Apposite Capital fund has been set up with £100m to provide much-needed scale-up funding for UK biopharma and healthtech companies.
News
Lilly says Foundayo safety confirmed in ACHIEVE-4 trial
Eli Lilly's ACHIEVE-4 trial results for oral GLP-1 Foundayo set up a filing in diabetes, and provide safety data sought by the FDA.
News
Beeline raises $300m for BMS drugs, and other biofinancings
Beeline Medicines, Oricell, Terremoto, Harbinger, Neomorph, Adcendo, and STORM all closed impressive financing rounds in the last week.
R&D
3 big unanswered questions about psychedelics
When it comes to psychedelics in the mental health space, there are still some important foundational questions lacking settled answers.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
